Feasibility of Intensity-modulated Radiotherapy to Treat Gastric Cancer

Overview

Journal Rep Pract Oncol Radiother

Specialty Oncology

Date 2018 Nov 28

PMID 30479581

Authors

Agnieszka Skrobala

Marta Adamczyk

Aldona Karczewska-Dzionk

Affiliations

Soon will be listed here.

Abstract

Aim: To present a proposed gastric cancer intensity-modulated radiotherapy (IMRT) treatment planning protocol for an institution that have not introduced volumetric modulated arc therapy in clinical practice. A secondary aim was to determine the impact of 2DkV set-up corrections on target coverage and organ at risk (OAR).

Methods And Materials: Twenty consecutive patients were treated with a specially-designed non-coplanar 7-field IMRT technique. The isocenter-shift method was used to estimate the impact of 2DkV-based set-up corrections on the original base plan (BP) coverage. An alternative plan was simulated (SP) by taking into account isocenter shifts. The SP and BP were compared using dose-volume histogram (DVH) plots calculated for the internal target volume (ITV) and OARs.

Results: Both plans delivered a similar mean dose to the ITV (100.32 vs. 100.40%), with no significant differences between the plans in internal target coverage (5.37 vs. 4.96%). Similarly, no significant differences were observed between the maximal dose to the spinal cord (67.70 and 67.09%, respectively) and volume received 50% of the prescribed dose of: the liver (62.11 vs. 59.84%), the right (17.62 vs. 18.58%) and left kidney (29.40 vs. 30.48%). Set-up margins (SM) were computed as 7.80 mm, 10.17 mm and 6.71 mm in the left-right, cranio-caudal and anterior-posterior directions, respectively.

Conclusion: Presented IMRT protocol (OAR dose constraints with selected SM verified by 2DkV verification) for stomach treatment provided optimal dose distribution for the target and the critical organs. Comparison of DVH for the base and the modified plan (which considered set-up uncertainties) showed no significant differences.

References

Strbac B, Jokic V . Evaluation of set-up errors in head and neck radiotherapy using electronic portal imaging. Phys Med. 2013; 29(5):531-6. DOI: 10.1016/j.ejmp.2012.12.001. View

Isobe K, Uno T, Kawakami H, Ueno N, Kawata T, Ito H . A case of gastric lymphoma with marked interfractional gastric movement during radiation therapy. Int J Clin Oncol. 2006; 11(2):159-61. DOI: 10.1007/s10147-005-0557-y. View

Macdonald J, Smalley S, Benedetti J, Hundahl S, Estes N, STEMMERMANN G . Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001; 345(10):725-30. DOI: 10.1056/NEJMoa010187. View

Boda-Heggemann J, Hofheinz R, Weiss C, Mennemeyer P, Mai S, Hermes P . Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer. Int J Radiat Oncol Biol Phys. 2009; 75(4):1187-95. DOI: 10.1016/j.ijrobp.2008.12.036. View

Leszczynski W, Polanowski P, Leszczynska P, Hawrylewicz L, Braclik I, Kawczynski R . Can we obtain planning goals for conformal techniques in neoadjuvant and adjuvant radiochemotherapy for gastric cancer patients?. Rep Pract Oncol Radiother. 2016; 21(3):149-55. PMC: 5002022. DOI: 10.1016/j.rpor.2015.11.008. View

Van Herk M . Errors and margins in radiotherapy. Semin Radiat Oncol. 2004; 14(1):52-64. DOI: 10.1053/j.semradonc.2003.10.003. View

Turanli S, Atalay C, Berberoglu U, Gulben K . Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent. J Cancer Res Ther. 2015; 11(2):369-74. DOI: 10.4103/0973-1482.160050. View

Kost S, Dorr W, KEINERT K, Endert G, Herrmann T . Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy. Int J Radiat Biol. 2002; 78(8):695-702. DOI: 10.1080/09553000210134791. View

Astreinidou E, Bel A, Raaijmakers C, Terhaard C, Lagendijk J . Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys. 2005; 61(3):938-44. DOI: 10.1016/j.ijrobp.2004.11.016. View

10.

Valentini V, Cellini F, Minsky B, Mattiucci G, Balducci M, DAgostino G . Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol. 2009; 92(2):176-83. DOI: 10.1016/j.radonc.2009.06.014. View

11.

Isa N . Evidence based radiation oncology with existing technology. Rep Pract Oncol Radiother. 2014; 19(4):259-66. PMC: 4104019. DOI: 10.1016/j.rpor.2013.09.002. View

12.

Bortfeld T, Van Herk M, Jiang S . When should systematic patient positioning errors in radiotherapy be corrected?. Phys Med Biol. 2002; 47(23):N297-302. DOI: 10.1088/0031-9155/47/23/401. View

13.

Stroom J, Heijmen B . Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiother Oncol. 2002; 64(1):75-83. DOI: 10.1016/s0167-8140(02)00140-8. View

14.

Bortfeld T, Jokivarsi K, Goitein M, Kung J, Jiang S . Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. Phys Med Biol. 2002; 47(13):2203-20. DOI: 10.1088/0031-9155/47/13/302. View

15.

Adamczyk M, Piotrowski T, Adamiak E, Malicki J . Dosimetric consequences of prostate-based couch shifts on the precision of dose delivery during simultaneous IMRT irradiation of the prostate, seminal vesicles and pelvic lymph nodes. Phys Med. 2013; 30(2):228-33. DOI: 10.1016/j.ejmp.2013.06.003. View

16.

Gill S, Thomas J, Fox C, Kron T, Thompson A, Chander S . Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties. Br J Radiol. 2011; 85(1010):176-82. PMC: 3473946. DOI: 10.1259/bjr/13553326. View

17.

Minn A, Hsu A, La T, Kunz P, Fisher G, Ford J . Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer. Cancer. 2010; 116(16):3943-52. DOI: 10.1002/cncr.25246. View

18.

Smalley S, Benedetti J, Haller D, Hundahl S, Estes N, Ajani J . Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012; 30(19):2327-33. PMC: 4517071. DOI: 10.1200/JCO.2011.36.7136. View

19.

van Herk M, Remeijer P, Rasch C, Lebesque J . The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000; 47(4):1121-35. DOI: 10.1016/s0360-3016(00)00518-6. View

20.

Milano M, Garofalo M, Chmura S, Farrey K, Rash C, Heimann R . Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol. 2006; 79(942):497-503. DOI: 10.1259/bjr/43441736. View